|  |  | FC0091
 Ribosomal protein S6 kinase alpha-1 (RSK1)
	   -  S100B
 Biological function
 RSK1 is a MAPK activated protein kinase, which belongs to the calmodulin-dependent kinase (CaMK) superfamily. Binding to 
S100B negatively affects phosphorylation of RSK1 by ERK. S100B binds to a C-terminal RSK1 segment that is required not only 
for ERK2 recruitment but also for the autoinhibition of the RSK1 CaMK-type domain. Thus S100B not only directly interferes 
with the assembly of the ERK2-RSK1 heterodimeric complex, but also negatively affects the activity of the CaMK-type domain of 
RSK1.
 
 Domain organization/sequence features
 Tandem kinase: N-terminal AGC type kinase domain, C-terminal CaMK type domain.
 
 Structural evidence
 Crystal structures of RSK1 constructs with N-terminal truncations at 683, 689, 696 in complex with S100B have been 
determined. The RSK1 peptides exhibited very different bound conformations, but only very short regions of the 683-735 
segment could be localized (697-704, 725-731), the rest of the sequence remained to be disordered in the complex. The 
polymorphic nature of the bound conformations is also illustrated by the diversity of secondary structures adopted by the linear 
motif upon interacting with the canonical docking site: coil and helix, respectively. HSQC spectrum of the intervening segment 
(clamp) remain unchanged upon S100B binding. SAXS data indicate interactions between the N-terminal region of RSK1 and 
S100B, in addition to a population, where the NTD is extended and is not in contact with the partner.
 
 Biochemical evidence
 Affinity of the C terminal region of RSK1 (712-735 AA) for S100B is KD=4 μM, while the segment including 683-735 
AA makes high affinity binding with KD=40 nM. Mutation of any of the 685-688 residues to Ala decreased binding 
by one order of magnitude.
 
 Structure/Mechanism
 Conformational heterogeneity of RSK1 corresponds to auto-inhibited and released states, depending on the position of the C-
terminal αL helix. Kinetic measurements show that the S100B-inhibited state corresponds ~44% of the population.
 
 Mechanism category
 conformational selection, tethering
 
 Significance
 Fuzziness enables and allosteric inhibition of S100B by shifting the bound conformational ensemble of RSK1 from released to
auto-inhibited state.
 
 Medical relevance
 In malignant melanomas the first phosphorylation event of the MAPK pathway by ERK2 on RSK1 is inhibited by Ca2+
-binding S100 proteins.
 
 Submitted by
 Laszlo Nyitray   nyitray@elte.hu
 
 
 
   |  |